We are live on ! Find out more
EFMH

E Fund Management (HK) Portfolio holdings

AUM $302M
1-Year Est. Return 64.42%
This Fund
S&P 500
This Quarter Est. Return
-1.42%
1 Year Est. Return
+64.42%
3 Year Est. Return
+162.67%
5 Year Est. Return
10 Year Est. Return
AUM
$220M
AUM Growth
-$77.6M
Cap. Flow
-$8.42M
Cap. Flow %
-3.83%
Top 10 Hldgs %
51.43%
Holding
506
New
110
Increased
201
Reduced
59
Closed
15

Top Sells

Rank Stock Value
1
ATO icon
Atmos Energy
ATO
+$5.47M
2
NEM icon
Newmont
NEM
+$3.12M
3
AEM icon
Agnico Eagle Mines
AEM
+$2.78M
4
AAPL icon
Apple
AAPL
+$2.17M
5
B
Barrick Mining
B
+$2.14M

Sector Composition

Rank Sector Weight
1 Technology 25.42%
2 Consumer Discretionary 23.57%
3 Communication Services 10.84%
4 Materials 9.73%
5 Consumer Staples 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCVX icon
276
Vaxcyte
PCVX
$7.81B
$14.1K 0.01%
+243
New +$13.2K
HLN icon
277
Haleon
HLN
$43.5B
$14K 0.01%
+1,402
New +$14.6K
TEVA icon
278
Teva Pharmaceuticals
TEVA
$40.8B
$14K 0.01%
+464
New +$14.9K
MRNA icon
279
Moderna
MRNA
$21.8B
$13.9K 0.01%
+274
New +$12.8K
RDY icon
280
Dr. Reddy's Laboratories
RDY
$9.87B
$13.9K 0.01%
+1,001
New +$13.9K
CVS icon
281
CVS Health
CVS
$133B
$13.9K 0.01%
193
+144
+294% +$11.1K
HALO icon
282
Halozyme
HALO
$9.79B
$13.8K 0.01%
+214
New +$15.1K
BLSH
283
Bullish
BLSH
$3.3B
$13.8K 0.01%
+385
New +$13.5K
VTRS icon
284
Viatris
VTRS
$20.4B
$13.8K 0.01%
+1,018
New +$14.2K
NVS icon
285
Novartis
NVS
$297B
$13.7K 0.01%
+90
New +$13.8K
NVO
286
Novo Nordisk
NVO
$208B
$13.7K 0.01%
+374
New +$17.7K
ASND icon
287
Ascendis Pharma A/S
ASND
$16B
$13.7K 0.01%
+60
New +$13.4K
DIS icon
288
Walt Disney
DIS
$167B
$13.5K 0.01%
140
+72
+106% +$7.61K
ED icon
289
Consolidated Edison
ED
$40.1B
$13.5K 0.01%
119
ELV icon
290
Elevance Health
ELV
$81.5B
$13.5K 0.01%
46
+44
+2,200% +$14.5K
BLK icon
291
Blackrock
BLK
$169B
$13.5K 0.01%
14
+13
+1,300% +$13.7K
O icon
292
Realty Income
O
$59.6B
$13.5K 0.01%
220
+214
+3,567% +$13.4K
GRFS
293
Grifois
GRFS
$5.36B
$13.5K 0.01%
+1,678
New +$14.8K
IMVT icon
294
Immunovant
IMVT
$7.93B
$13.4K 0.01%
+541
New +$14K
BLCO icon
295
Bausch + Lomb
BLCO
$6.04B
$13.4K 0.01%
+845
New +$14.4K
RYTM icon
296
Rhythm Pharmaceuticals
RYTM
$6.81B
$13.4K 0.01%
+154
New +$15K
BMRN icon
297
BioMarin Pharmaceuticals
BMRN
$11.6B
$13.3K 0.01%
+236
New +$13.8K
CIFR icon
298
Cipher Digital
CIFR
$9.13B
$13.3K 0.01%
+1,034
New +$16.4K
GIS icon
299
General Mills
GIS
$19.1B
$13.3K 0.01%
356
+346
+3,460% +$15K
BLTE
300
Belite Bio
BLTE
$6.36B
$13.2K 0.01%
+83
New +$14K

Similar funds

E Fund Management (HK)'s Q1 2026 Portfolio in Review

As of Q1 2026, E Fund Management (HK) held 506 positions worth $220M, down 26% from $297M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

E Fund Management (HK) withdrew a net $8.42M in Q1 2026, closing 15 positions and reducing 59 holdings. Its most notable exit was Qfin Holdings, an estimated $636K position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, E Fund Management (HK) opened a new position in AngloGold Ashanti worth $1.73M.

  • E Fund Management (HK)'s largest Q1 2026 buy was AngloGold Ashanti: 17,747 shares worth $1.73M.
  • E Fund Management (HK) added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.07M increase.
  • E Fund Management (HK)'s biggest Q1 2026 reduction was Atmos Energy, cutting an estimated $5.47M.
  • E Fund Management (HK) fully exited Qfin Holdings in Q1 2026, selling an estimated $636K.
  • E Fund Management (HK)'s ten largest holdings make up 51% of its $220M portfolio in Q1 2026.
  • E Fund Management (HK) opened 110 new positions and closed 15 in Q1 2026.
  • E Fund Management (HK)'s portfolio value fell 26% quarter-over-quarter to $220M.

Based on E Fund Management (HK)'s 13F filing for Q1 2026, filed 8 Apr 2026.